EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity

Fibi Meshrkey, Somaya Y Ibrahim iD, Rushita A Bagchi, William J Richardson iD

Cells · 2025

DOI: 10.3390/cells14181471 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Fibi Meshrkey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ralph E. Martin Department of Chemical Engineering, University of Arkansas, Fayetteville, AR 72701, USA. Hauptthemen laut MEDLINE: Extracellular Matrix, Anthracyclines, Cardiotoxicity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: R.A.B. received support through a career development award from the American Heart Association, Vice Chancellor for Research and Innovation (VCRI) and the Arkansas Biosciences Institute, the Sturgis Grant for Diabetes Research from the College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines are widely used chemotherapeutic agents with proven efficacy against a broad range of malignancies, but their clinical utility is limited by a well-documented, dose-dependent cardiotoxicity. While this toxicity has traditionally been attributed to direct cardiomyocyte injury, emerging evidence highlights the pivotal role of cardiac fibroblasts (CFs) in the development and progression of anthracycline-induced cardiotoxicity. This review examines the diverse effects of anthracycline focusing on doxorubicin (DOX) and CFs across the temporal phases of cardiac injury. DOX activates fibroblast-driven extracellular matrix remodeling and promotes fibrosis through enhanced collagen production and the induction of cellular senescence, thereby exacerbating early myocardial inflammation and dysfunction. Clinically, anthracycline cardiotoxicity may present as acute (within days), subacute (within weeks), or chronic progressive forms manifesting either early (within one year) or late (up to decades post-treatment). While early manifestations may be reversible with timely detection and management, late-phase cardiotoxicity is often irreversible, characterized by declining left ventricular ejection fraction and heart failure. A deeper understanding of the molecular and cellular contributions of CFs may uncover novel therapeutic targets to prevent or attenuate anthracycline-related cardiac damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular MatrixAnthracyclinesCardiotoxicityHumansAnimalsDoxorubicinFibrosisFibroblasts

Stichwörter der Autor:innen

anthracyclinecardiotoxicitydoxorubicinextracellular Matrixfibrosis

Substanzen

AnthracyclinesDoxorubicin

Autor:innen und Institutionen

  • Ralph E. Martin Department of Chemical Engineering, University of Arkansas, Fayetteville, AR 72701, USA.
  • PharmD Program, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

ORCID-Profile: Somaya Y Ibrahim, William J Richardson

Förderung

  • R.A.B. received support through a career development award from the American Heart Association
  • Vice Chancellor for Research and Innovation (VCRI) and the Arkansas Biosciences Institute
  • the Sturgis Grant for Diabetes Research from the College of Medicine
  • the Medical Research Endowment Grant from the University of Arkansas for Medical Sciences
  • American Heart Association
  • Vice Chancellor for Research and Innovation (VCRI)
  • Sturgis Grant for Diabetes Research
  • University of Arkansas for Medical Sciences

Zitieren

APA

Meshrkey, F., Ibrahim, S. Y., Bagchi, R. A., & Richardson, W. J. (2025). Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity. Cells. https://doi.org/10.3390/cells14181471

Vancouver

Meshrkey F, Ibrahim SY, Bagchi RA, Richardson WJ. Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity. Cells. 2025. doi:10.3390/cells14181471

BibTeX
@article{Meshrkey2025,
  author = {Meshrkey, Fibi and Ibrahim, Somaya Y and Bagchi, Rushita A and Richardson, William J},
  title = {Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14181471}
}
Kostenlos starten →